- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/92 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
Patent holdings for IPC class C07D 211/92
Total number of patents in this class: 47
10-year publication summary
|
1
|
4
|
3
|
2
|
1
|
2
|
2
|
1
|
4
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alkermes Pharma Ireland Limited | 256 |
5 |
| ChemoCentryx, Inc. | 370 |
3 |
| Bayer Intellectual Property GmbH | 2395 |
2 |
| Albert Einstein College of Medicine, Inc. | 593 |
2 |
| Kobelco Eco-solutions Co., Ltd. | 126 |
2 |
| Corteva Agriscience LLC | 2648 |
2 |
| Bristol-myers Squibb Company | 4789 |
1 |
| 3m Innovative Properties Company | 17491 |
1 |
| The Regents of the University of California | 20590 |
1 |
| Merck Sharp & Dohme Corp. | 2183 |
1 |
| FUJIFILM Corporation | 30327 |
1 |
| Massachusetts Institute of Technology | 10204 |
1 |
| Bridgestone Corporation | 7238 |
1 |
| Board of Regents, The University of Texas System | 6065 |
1 |
| The General Hospital Corporation | 4840 |
1 |
| President and Fellows of Harvard College | 6060 |
1 |
| Vertex Pharmaceuticals Incorporated | 1589 |
1 |
| Duke University | 3172 |
1 |
| Albert Einstein College of Medicine of Yeshiva University | 132 |
1 |
| Chiesi Farmaceutici S.p.A. | 961 |
1 |
| Other owners | 17 |